5 | COE 32% v632K c1.6074 f22,27M H1.64 | znewcar1 | 07/12/2022 10:42:58 PM |
4 | COE 27% v5,7M c2.03 f21,5M H2.18 EOD | znewcar1 | 02/14/2022 4:24:37 PM |
3 | COE 23% v2,29M c1.59 f21,5M morning pop back to O | znewcar1 | 02/11/2022 11:13:33 PM |
2 | COE 24% v3,2M c1.29 f21,5M H1.5 | znewcar1 | 02/10/2022 6:51:17 PM |
1 | COE 21% v1,4M c2.85 f21,5M | znewcar1 | 09/27/2021 5:10:11 PM |
Recent Articles
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement
- Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
- OFS Credit Company Shares November Net Asset Value Insights
- New FDA Approval for Crenessity Enhances CAH Treatment Options
- Q-Gold Secures Initial Funding for New Exploration Ventures
- Capital Power's Genesee Project Marks Major Energy Milestone
- Viridian Therapeutics Set to Present Veligrotug Results Soon
- Ensuring Safe Travels: King County's Holiday Traffic Initiative
- Acadia Healthcare Faces Class Action Amid Significant Losses
- S&P Dow Jones Indices Reveals Results of 2024 DJSI Review
- Celebrating Entrepreneurial Success: The Impact of MBDA
- Village Super Market's Dividend Announcement and Growth Plans
- Digi International Welcomes New Executive Leaders to Board
- Transfusion Market Expected to Rise by $2.6 Billion: Insights
- CenterPoint Energy Announces Increased Quarterly Dividend Payout
- Shobha Launches Exciting Offers and Convenient Memberships
- ANSC Secures Key Approval for Upcoming Business Combination
- Barite Market Forecast: Growth Driven by Oil and AI Trends
- Contract Cleaning Services: Driving Growth with AI Innovation
- Lochmere Association Recognized for Eco-Friendly Excellence
- Fairholme Funds Announcement: December Dividend Details
- Empowering Change: Vigil for Clemency at the White House
- Boar's Head Reaches Settlement in Landmark Listeria Case
- Discover the SR6800 Window: Where History Meets Innovation
- Turkish Airlines Announces New Lounge at JFK's Terminal One
- AI Innovations Fuel Growth in the Analytical Standards Market
- Understanding the Seafood Market: Trends and Innovations
- Univest Securities Completes $2.7 Million Offering for LICN
- CubeSmart Declares Quarterly Dividend Increase for Shareholders
- Douglas Emmett Inc. Announces Cash Dividend for Shareholders
- Galderma's Breakthrough Approval of Nemluvio for Atopic Dermatitis